Evidence map›Paper›PMID 31640239›Full record

ArticleBrain sciences2019

The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease.

Jung Goo Lee, Young Sup Woo, Sung Woo Park, Dae-Hyun Seog, Mi Kyoung Seo, Won-Myong Bahk

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Brain sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 69 citations in OpenAlex.

  1. Gut-brain axis in health and brain disease.Chinese medical journal · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Dietary supplements and prevention of preeclampsia.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jung Goo LeeDepartment of Psychiatry, College of Medicine, Haeundae Paik Hospital, Inje University, Busan 47392, Korea. iybihwc@inje.ac.kr.ORCID 0000-0003-3393-2667
Young Sup WooDepartment of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul 07345, Korea. youngwoo@catholic.ac.kr.
Sung Woo ParkPaik Institute for Clinical Research, Department of Health Science and Technology, Graduate School, Inje University, Busan 47392, Korea. swpark@inje.ac.kr.
Dae-Hyun SeogDepartment of Biochemistry, College of Medicine, Inje University, Busan 47392, Korea. daehyun@inje.ac.kr.
Mi Kyoung SeoPaik Institute for Clinical Research, Inje University, Busan 47392, Korea. banaba66@inje.ac.kr.ORCID 0000-0002-3368-4950
Won-Myong BahkDepartment of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul 07345, Korea. wmbahk@catholic.ac.kr.
Inje University · KRCatholic University of Korea · KRInje University Busan Paik Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melatonin is a hormone that is secreted by the pineal gland. To date, melatonin is known to regulate the sleep cycle by controlling the circadian rhythm. However, recent advances in neuroscience and molecular biology have led to the discovery of new actions and effects of melatonin. In recent studies, melatonin was shown to have antioxidant activity and, possibly, to affect the development of Alzheimer's disease (AD). In addition, melatonin has neuroprotective effects and affects neuroplasticity, thus indicating potential antidepressant properties. In the present review, the new functions of melatonin are summarized and a therapeutic target for the development of new drugs based on the mechanism of action of melatonin is proposed.

Indexed as

antidepressantantioxidantmelatoninneuroprotective effectoxydative stress

Identifiers

PMID31640239
PMCPMC6826722
OpenAlexW2980355127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.